And the combination of IL-6 inhibitor with anti-T cell immunoglobulin mucin-3 (anti-Tim-3) enhances the efficacy of T cell-mediated killing of tumor cells (26, 76). The gene discussed is HAVCR2; the disease is neoplasm.